Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Does Bristol-Myers Squibb Look Like a Winning Investment?
Motley Fool
Wednesday, August 24, 2011 - 10:01pm
tags:
Bristol-Myers Squibb
Docs wary of any biosimilars that lack compelling data
Fierce Biotech
Wednesday, August 24, 2011 - 10:50am
tags:
physicians, biosimilars
Takeda in talks with Lupin, Cipla to buy pharma businesses
Stock Market Digital
Wednesday, August 24, 2011 - 10:47am
tags:
M&A, Cipla, Lupin, Takeda, India
FDA Is Petitioned To Add Black Boxes For PPIs
Pharmalot
Wednesday, August 24, 2011 - 10:22am
tags:
FDA, black box, PPIs, acid reflux, proton pump inhibitors
Biotech-On-The-Verge Ampio Pharmaceuticals Bolsters Its Management
Seeking Alpha
Wednesday, August 24, 2011 - 10:20am
tags:
Ampio Pharmaceuticals
Pfizer & Bristol-Myers to Release Highly Anticipated Data on Bloodthinner Hopeful
Motley Fool
Wednesday, August 24, 2011 - 10:19am
tags:
Pfizer, Bristol-Myers Squibb, Eliquis, bloodthinners, Apixaban
Drug Rep Arrested, Charged With Stealing Pills From Pharmacy
4029tv.com
Wednesday, August 24, 2011 - 10:18am
tags:
drug reps, oxycodone
Par Pharma to buy generic drugmaker Anchen for $410 mln
Reuters
Wednesday, August 24, 2011 - 9:32am
tags:
Par Pharmaceutical, generics, M&A, Anchen
Canadian Launch Of Onsolis Has BioDelivery On The Radar
Seeking Alpha
Wednesday, August 24, 2011 - 9:27am
tags:
BioDelivery Sciences, Onsolis, Canada, Meda, Valeant Pharmaceuticals, breakthrough pain, cancer
Peregrine Reports Promising 20.7 Month Median Overall Survival From Phase II Advanced Breast Cancer Trial
Yahoo
Wednesday, August 24, 2011 - 9:23am
tags:
Peregrine Pharmaceuticals, breast cancer, monoclonal antibodies, bavituximab, lung cancer
United Therapeutics shares tumble on clinical trial failure
Bizjournals.com
Wednesday, August 24, 2011 - 9:19am
tags:
United Therapeutics, PAH, treprostinil diethanolamine
Zogenix plans public offering of 12 million shares
Yahoo/AP
Wednesday, August 24, 2011 - 9:17am
tags:
Zogenix, stock offering
Upstart biotech banks $13M for new eye drugs
Fierce Biotech
Tuesday, August 23, 2011 - 7:30pm
tags:
eye health, ophthalmology, KalVista, Novo A/S, SV Life Sciences
Vivus to raise $45.8M in direct offering
Bizjournals.com
Tuesday, August 23, 2011 - 7:27pm
tags:
Vivus, stock offering
J&J Aims For EU Approval For Prostate Cancer Drug
Investors.com
Tuesday, August 23, 2011 - 7:23pm
tags:
prostate cancer, JNJ, Zytiga, Europe
Drugmaker Payments to Scientists Face New Disclosure Controls
Bloomberg
Tuesday, August 23, 2011 - 12:31pm
tags:
scientist payments
'More bang for buck' from GSK's Cervarix
Fierce Pharma
Tuesday, August 23, 2011 - 12:04pm
tags:
HPV, GSK, Cervavix, vaccines, Gardasil, Merck, anal cancer
Contract Drug Manufacturing Is Forecast To Explode
Pharmalot
Tuesday, August 23, 2011 - 12:00pm
tags:
contract drug manufacturing
5 Life Sciences Stocks Insiders Are Buying
Motley Fool
Tuesday, August 23, 2011 - 11:59am
tags:
Life Technologies, Pacific Biosciences, Mettler-Toledo, Affymetrix, Complete Genomics
Is Amgen a Buffett Stock?
Motley Fool
Tuesday, August 23, 2011 - 11:58am
tags:
Warren Buffett, Amgen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.